Colloidal modified fluid gelatin plasma substitute
Term · Oncology and biomedicine · MLC-T-ONC-012706
A colloidal, isotonic, physiologically balanced, plasma volume substitute containing succinylated gelatine and electrolytes, with potential nephroprotective properties. Upon intravenous administration, colloidal modified fluid gelatin plasma substitute expands the blood volume, restores intravascular volume and increases blood flow, thereby preventing hypovolemia, hypotension and shock and may decrease the accumulation of nephrotoxic agents in the kidneys.
| Identifier | MLC-T-ONC-012706 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | colloidal succinylated gelatine plasma substitute |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012706",
"term": "Colloidal modified fluid gelatin plasma substitute",
"field": "Oncology and biomedicine",
"definition": "A colloidal, isotonic, physiologically balanced, plasma volume substitute containing succinylated gelatine and electrolytes, with potential nephroprotective properties. Upon intravenous administration, colloidal modified fluid gelatin plasma substitute expands the blood volume, restores intravascular volume and increases blood flow, thereby preventing hypovolemia, hypotension and shock and may decrease the accumulation of nephrotoxic agents in the kidneys.",
"synonyms": [
"colloidal succinylated gelatine plasma substitute"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/colloidal-modified-fluid-gelatin-plasma-substitute/"
}
Record 5,102 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.